IP Group news – IP Group plc

Search in site

2022 data tab

Date	Title
06 Jan 2021	IP Group plc Portfolio company Oxbotica completes £36m funding round
03 Dec 2020	IP Group plc Portfolio company Artios and Merck KGaA, Darmstadt, Germany announce a global strategic collaboration on novel DNA Damage Response targets in oncology
13 Oct 2020	IP Group plc Portfolio company Oxford Nanopore Technologies announces £84.4m of additional funding
09 Oct 2020	IP Group plc Portfolio company Oxford Nanopore Technologies announces LamPORE test, for the detection of SARS-CoV-2, gains CE-IVD mark with initial roll out in Europe and the UAE
07 Oct 2020	IP Group plc Portfolio company Enterprise Therapeutics’ TMEM16A potentiator program for treatment of cystic fibrosis & other respiratory diseases acquired by Roche
17 Aug 2020	IP Group plc Portfolio company MOBILion Systems completes $35m funding round
05 Aug 2020	IP Group plc Half-yearly results
04 Aug 2020	IP Group plc Launches £12m Investment Partnership in Quantum Technologies with InnovateUK
03 Aug 2020	IP Group plc Portfolio company Oxford Nanopore Technologies partners with UK Government to roll out LamPORE, a new generation of COVID-19 test
14 Jul 2020	IP Group plc Sells 9.16m shares in Ceres Power; cash realisations for the year now exceed £168m

Loadmore